NCT00027248View on ClinicalTrials.gov

Safety and Efficacy of MBI 226 for the Prevention of Central Venous Catheter-Related Bloodstream Infections

PHASE3CompletedINTERVENTIONAL
Enrollment

1,400

Participants

Timeline

Start Date

September 30, 2000

Study Completion Date

July 31, 2003

Conditions
SepsisBacteremiaFungemia
Interventions
DRUG

MBI 226

Trial Locations (1)

60044

Omnicare Clinical Research Inc., Lake Bluff

Sponsors
All Listed Sponsors
lead

BioWest Therapeutics Inc

INDUSTRY